Skip to main content
Em Prestige on Muck Rack

Em Prestige

As seen in: medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Em

Contact Em, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Classifying and Differentiating Individuals with Respiratory Syncytial Virus, Influenza, and COVID-19 Cases in OpenSAFELY Between 2016 and 2024

|
By Charlotte Warren-Gash, Jennifer K Quint, Em Prestige
| medRxiv
REC holds personal shares in AstraZeneca. EP was funded by National Institute for Health and Care Research (NIHR); grant number: NIHR303287. RME was supported by the Medical Research Council (MR/X033260/1), and the National Institute for Health and Care Research (NIHR) Health Protection Research Unit in Health Analytics & Modelling, a partnership between the UK Health Security Agency, Imperial College London and LSHTM (grant code NIHR207404).
Open in Who Shared Issue with article?
See all 1 articles